Cargando…
Oncologic immunomodulatory agents in patients with cancer and COVID-19
Corticosteroids, anti-CD20 agents, immunotherapies, and cytotoxic chemotherapy are commonly used in the treatment of patients with cancer. It is unclear how these agents affect patients with cancer who are infected with SARS-CoV-2. We retrospectively investigated associations between SARS-CoV-2-asso...
Autores principales: | Jee, Justin, Stonestrom, Aaron J., Devlin, Sean, Nguyentran, Teresa, Wills, Beatriz, Narendra, Varun, Foote, Michael B., Lumish, Melissa, Vardhana, Santosha A., Pastores, Stephen M., Korde, Neha, Patel, Dhwani, Horwitz, Steven, Scordo, Michael, Daniyan, Anthony F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921444/ https://www.ncbi.nlm.nih.gov/pubmed/33649382 http://dx.doi.org/10.1038/s41598-021-84137-5 |
Ejemplares similares
-
Supported Planar Bilayers for the Formation of Study of Immunological Synapses and Kinapse
por: Vardhana, Santosha, et al.
Publicado: (2008) -
Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion
por: Noy, Ariela, et al.
Publicado: (2022) -
The many faces of the anti-COVID immune response
por: Vardhana, Santosha A., et al.
Publicado: (2020) -
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
por: Lumish, Melissa, et al.
Publicado: (2021) -
Critical Care and Oncology
por: Pastores, Stephen M.
Publicado: (2021)